Skip Navigation
AIDSInfo logo
HIV Vaccine
Awareness Day

May 18, 2006


HIV Vaccine Awareness Day logo May 18 marks the ninth annual observance of HIV Vaccine Awareness Day. On this day, community activities and media events around the country will focus on educating people about the importance of HIV vaccine research. It's also a day to recognize and thank volunteers, community members, health professionals, and scientists for their continued commitment to finding a vaccine to prevent the spread of HIV.

A preventive HIV vaccine offers the best hope for controlling the AIDS pandemic. On May 18, wear your red AIDS ribbon upside down—forming a "V" for vaccine—as a sign that you share the hope of victory in finding a vaccine to prevent HIV infection.

The following links provide information related to HIV Vaccine Awareness Day, including information on vaccine research, clinical trials, and other online HIV vaccine resources.
En Español
HIV Vaccine Awareness Day Sites
• National Institute of Allergy and Infectious Diseases (NIAID): The NIAID HIV Awareness Day page provides information about events and activities for HIV Vaccine Awareness Day.
• Statement of Anthony S. Fauci, M.D., Director, Margaret Johnston, Ph.D., Assistant Director for HIV/AIDS Vaccines, and Gary J. Nabel, M.D. Ph.D., Director, Vaccine Research Center, National Institute of Allergy and Infectious Diseases National Institutes of Health on HIV Vaccine Awareness Day May 18, 2006
• Office of Minority Health
• CDC Spotlight: HIV Vaccine Awareness Day
AIDSinfo Resources
• AIDSinfo Preventive HIV Vaccines: Fact sheet about preventive HIV vaccines.
• AIDSinfo Vaccine Web Page: Information on preventive and therapeutic HIV/AIDS vaccine research is found in this section of the AIDSinfo Web site. Includes comprehensive information about current HIV vaccine trials.
Online HIV Vaccine Resources
• HIV Vaccines Explained: A brochure published by the NIAID, explaining HIV vaccines—what an HIV vaccine is, why an HIV vaccine is important, preventive versus therapeutic vaccines, vaccine availability, and vaccine testing.
• HIV Vaccine Glossary from the NIAID: Defines HIV vaccine-related terms.
• Understanding Vaccines: A brochure published by the NIAID that explains vaccines.
• Challenges in Designing HIV Vaccines: Fact sheet from the NIAID explaining immune protection and the challenges of designing an HIV vaccine.
HIV Vaccine Research
• HIV Vaccine Trials Network: An international collaboration of scientists, educators, and clinical trial volunteers doing research to find an HIV vaccine.
• The NIAID Division of AIDS—HIV Vaccines: Comprehensive overview of
AIDS vaccine research and development.
• WHO—UNAIDS HIV Vaccine Initiative: Organization that promotes development, facilitates evaluation, and addresses future availability of preventive HIV vaccines, with a focus on developing countries.
• The Dale and Betty Bumpers Vaccine Research Center (VRC): at the National Institutes of Health was established to facilitate research in vaccine development, particularly for HIV/AIDS vaccines.
• NIH FY 2007 Plan for HIV-Related Research: Vaccines developed by the Office of AIDS Research.
• Partnerships for AIDS Vaccine Evaluation PAVE is a voluntary consortium of U.S. government agencies and key U.S. government-funded organizations involved in the development and evaluation of HIV/AIDS preventive vaccines and the conduct of HIV vaccine clinical trials.
• White House fact sheet about the Global HIV Vaccine Enterprise.
Preventive HIV Vaccine Clinical Trial Information
• HIV Vaccine Trials Network: Clinical trial sites for HIV vaccine testing.
• U.S. Military HIV Research Program: This network includes an international laboratory and clinical testing system through which candidate vaccines are created and evaluated.
• Preventive HIV Vaccine Clinical Trials: Information on ClinicalTrials.gov about federally
and privately sponsored preventive HIV vaccine clinical trials worldwide.
• VRC Clinical Trials information.
HIV Vaccine News
• Development of Preventive HIV Vaccines for Use in Pediatric Populations: FDA guidance providing recommendations to sponsors regarding data to support the (1) initiation of pediatric studies of a preventive HIV vaccine under a United States (U.S.) investigational new drug application (IND); and (2) licensure of a preventive HIV vaccine for pediatric use. The guidance also provides recommendations to investigators and institutional review boards (IRBs) who are involved with these pediatric studies.
• HIV/AIDS Vaccine News from AIDSinfo: Press releases from May of 2002 to October 2005.
• HIV Vaccine Trials Network Press Releases: Press releases from May 2001 through March 2006.
• AIDS Vaccine 2006 Conference: Information about the 2006 AIDS Vaccine Conference, being held August 29, until September 1, 2006, in Amsterdam.